RT Book, Section
A1 Douglas, Vanja C.
A1 Aminoff, Michael J.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193129078
T1 Dementia
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193129078
RD 2024/04/19
AB Key  Clinical  Updates  in  DementiaAducanumab  was  approved  by  the  FDA  despite  mixed  results  in  clinical  trials.  Its  use  is  limited  to  patients  with  mild  cognitive  impairment  or  mild  dementia  and  amyloid  pathology  proven  by  amyloid  PET.  The  ultimate  role  of  this  medication  is  still  being  debated.